Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhengzhou Sino-American Dongfeng Biological Pharmacy is a specialized pharmaceutical enterprise based in Zhengzhou, China, focusing on the development and manufacture of veterinary biological products. The company operates as a high-tech joint venture, primarily producing vaccines and therapeutic treatments for the livestock and poultry industries. Its product portfolio includes vaccines for major animal diseases such as swine fever and avian influenza, supported by GMP-certified manufacturing facilities. The firm emphasizes research and development to improve animal health and agricultural productivity within the Chinese market. By integrating international technology with local manufacturing, the company has established itself as a key provider of animal health solutions in the Henan province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhengzhou Sino-American Dongfeng Biological Pharmacy.